Conditions: Post Menopausal Osteoporosis
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 308
Healthy volunteers: no

Brief summary:
This study will evaluate whether an early positive response to once-monthly oral ibandronate in treatment-naive participants with postmenopausal osteoporosis is predictive of efficacy later in treatment. The anticipated time on study treatment is 6 months, and the target sample size is 360 individuals.

Detailed description:

Arms:
arm 1: Participants will receive a 6-month regimen with oral ibandronate, 150 mg once monthly. Group 1 will receive a physician consultation after 4 months of treatment to review bone turnover test results. arm 2: Participants will receive a 6-month regimen with oral ibandronate, 150 mg once monthly. Group 2 will not receive a physician consultation.

Interventions: intervention 1: Ibandronate
Intervention descriptions: intervention 1: Participants will receive oral ibandronate, 150 mg once weekly, for approximately 6 months.

Protocol document: